Institutional investors hold a majority ownership of ABBV through the 70.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2016, these large investors purchased a net $25.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PGGM VERMOGENSBEHEER BV Bought 1.1 Million shares of AbbVie
NATIONWIDE FUND ADVISORS Bought 371.0 Thousand shares of AbbVie
ATALANTA SOSNOFF MANAGEMENT LLC Bought 353.1 Thousand shares of AbbVie